In the midst of the growing infection of the corona virus, many countries are involved in the race to prepare its vaccine. Other countries including India, Britain, America, China and Russia are also seeing success in this. The vaccine prepared by Oxford University of Britain is also leading in this race. On Monday, the vaccine was reported to be successful in the first and second stage human trials. The next phase is preparing for a large-scale human trial, in addition to Britain, Brazil, the United States and then India.On the other hand, there are many types of questions in the mind of the people…. How long will it come in India, how will it be made available to the people, how much will the price be.

• After the trial of the corona vaccine of Oxford University, the preparation for its production has started. Indian company Serum Institute of India, one of the world's leading vaccine manufacturers, has started preparations for this. According to the company's CEO Adar Poonawala, the company will apply to the Indian Drug Controller General for trials of this vaccine in India as well.
• The head of the Serum Institute of India, Adar Poonawala, has told the media that the production of this vaccine has been reduced to $ 200 million in one stroke. He said that although this business decision can be risky, it has been decided considering its need. The Oxford University vaccine is expected to arrive in India by November.
• This week the results of the vaccine trial have been published in the medical journal Lancet Medical Journal. It states that the vaccine responded well during the trial and does not indicate any serious side effects. The vaccine is producing antibodies and T cells, which is effective in fighting the corona.
• Serum India has said that it can take up to two years to vaccinate all people in India. According to CEO Adar Poonawala, the company in India is confident of a third phase trial in August. He said, "We expect it to take two to two and a half months to complete and it will be completed by November. Half of the stock of Covishield manufactured at Serum Institute will be for India.
• The CEO of the company has clearly stated that out of about 60 million vials each month, India will get 30 million. It is estimated that the cost of this vaccine may be Rs 1000, but it is expected that the government in the country will purchase the vaccine and provide it free of cost to the people through vaccination campaign. Health experts say that unless the vaccination is done, the risk of this epidemic will remain.